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Abstract: Background 
The global economic crisis has been associated with increased 
unemployment and reduced public-sector expenditure on healthcare (PEH). 
We estimated the effects of changes in unemployment and PEH on cancer 
mortality, and identified how universal healthcare coverage (UHC) 
influenced the change. 
 
Methods 
Data were obtained from the World Bank and WHO (1990-2010). Mortality 
data from female breast, prostate, and colorectal cancers, which have 
survival rates that exceed 50%, were aggregated into a 'treatable' cancer 
class.  Lung and pancreatic cancers, which have five-year survival rates 
<10%, were likewise aggregated to give an 'untreatable' cancer category. 
Multivariable regression analysis was used, controlling for country-
specific demographics and infrastructure, with time-lag analyses and 
robustness checks to explore the relationship between unemployment and 
PEH on cancer mortality, with and without UHC. Trend analysis was used to 
project mortality rates based on trends prior to the sharp unemployment 
rise experienced by many countries from 2008 to 2010, and compare them 
with observed rates. 
 
Results 
Data were available for 75 countries (unemployment analysis) and 79 
countries (PEH analysis). Unemployment rises were significantly 
associated with an increase in all-cancer mortality and all specific 
cancers save for female-lung cancer. Untreatable cancer mortality by 
contrast was not significantly linked with changes in unemployment. Lag 
analyses showed significant associations remained five years after 
unemployment increases for the treatable cancer class. Re-running 
analyses while accounting for UHC status removed the significant 
associations. All-cancer, treatable cancer, and specific cancer 
mortalities significantly decreased as PEH increased. Associations held 
over a five-year period regardless of whether UHC was present. Time-
series analysis found just over 40 000 estimated excess deaths due to a 
subset of treatable cancers from 2008-2010 based on 2000-2007 trends. The 
great majority of these deaths were from non-UHC countries. 
 
Interpretation 
Unemployment increases are associated with cancer mortality increases. 
There is evidence that UHC protects against mortality increases 
associated with rises in unemployment, while PEH increases are associated 
with reduced cancer mortality. Reduced access to healthcare may underlie 
these associations. 
 
Funding 
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SUMMARY 34 
 35 
Background 36 
The global economic crisis has been associated with increased unemployment and reduced public-37 
sector expenditure on healthcare (PEH). We estimated the effects of changes in unemployment and PEH 38 
on cancer mortality, and identified how universal healthcare coverage (UHC) influenced the change. 39 
 40 
Methods 41 
Data were obtained from the World Bank and WHO (1990–2010). Mortality data from female breast, 42 
prostate, and colorectal cancers, which have survival rates that exceed 50%, were aggregated into a 43 
‘treatable’ cancer class.  Lung and pancreatic cancers, which have five-year survival rates <10%, were 44 
likewise aggregated to give an ‘untreatable’ cancer category. Multivariable regression analysis was 45 
used, controlling for country-specific demographics and infrastructure, with time-lag analyses and 46 
robustness checks to explore the relationship between unemployment and PEH on cancer mortality, 47 
with and without UHC. Trend analysis was used to project mortality rates based on trends prior to the 48 
sharp unemployment rise experienced by many countries from 2008 to 2010, and compare them with 49 
observed rates. 50 
 51 
Results 52 
Data were available for 75 countries (unemployment analysis) and 79 countries (PEH analysis). 53 
Unemployment rises were significantly associated with an increase in all-cancer mortality and all 54 
specific cancers save for female-lung cancer. Untreatable cancer mortality by contrast was not 55 
significantly linked with changes in unemployment. Lag analyses showed significant associations 56 
remained five years after unemployment increases for the treatable cancer class. Re-running analyses 57 
while accounting for UHC status removed the significant associations. All-cancer, treatable cancer, and 58 
specific cancer mortalities significantly decreased as PEH increased. Associations held over a five-year 59 
period regardless of whether UHC was present. Time-series analysis found just over 40 000 estimated 60 
excess deaths due to a subset of treatable cancers from 2008–2010 based on 2000–2007 trends. The 61 
great majority of these deaths were from non-UHC countries. 62 
 63 
Interpretation 64 
Unemployment increases are associated with cancer mortality increases. There is evidence that UHC 65 
protects against mortality increases associated with rises in unemployment, while PEH increases are 66 
associated with reduced cancer mortality. Reduced access to healthcare may underlie these associations. 67 
 68 
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INTRODUCTION 75 
 76 
The global economic crisis, which began in 2008, compelled many countries to cut public spending in 77 
order to reduce public-sector borrowing.
1
 These spending cuts often entailed either reductions or a 78 
flattening in public-sector jobs and public-sector expenditure on healthcare (PEH).
2,3
 Thirty three of 53 79 
WHO European region countries underwent no change in PEH between 2008 and 2009, while six 80 
experienced a reduction in PEH,
4
 which have prompted concerns about the possible negative effects on 81 
public health. Studies have demonstrated that long-term unemployment leads to increased suicide rates 82 
and reduced healthcare access.
5,6
 83 
 84 
Ecological studies exploring health-economic trends in the short run (separate from residual or secular 85 
trends) have thus far focused on macroeconomic changes and outcome indicators, such as suicide rates, 86 
cardiovascular disease incidence, all-cause mortality, and specific forms of cancer, but not cancer per 87 
se.
3,7–15
 These potential associations may predominantly be explained by behavioural, mental, or stress-88 
related changes with direct and immediate effects, whether, as in the case of suicides, they are counter-89 
cyclical associations linked to the direct psychological and financial impact of job loss,
16
 or pro-cyclical 90 
associations linked to reduced injury-related work and lifestyle activities in the case of all-cause 91 
mortality.
9
 Few studies, however, have analysed the relationship between economic downturns and 92 
cancer especially in countries that may be more susceptible to economic shocks due to limited social 93 
security and healthcare systems.  94 
 95 
Establishing a causal relationship between an economic change, such as aggregate unemployment, on 96 
cancer mortality is challenging, as downstream effects of unemployment-induced behavioural changes 97 
on lifestyle-related cancers manifest much later (20–30 years) than, for example, suicide or acute, 98 
stress-related cardiovascular events. However, access to healthcare and PEH may act as mediating 99 
factors with more immediate effects on health outcomes. One study on the Great Depression found 100 
deaths from cancer correlated with reduced income,
17
 although the lack of treatment options for patients 101 
presenting with late-stage disease meant that the effect of the economic downturn on reduced healthcare 102 
access and mortality could not be as strongly demonstrated as it could in an era where systemic 103 
treatment is now available. 104 
 105 
Cancer is one of the leading causes of death worldwide, accounting for 8.2 million deaths in 2012, with 106 
estimates suggesting a rise in annual cancer cases from 14 million in 2012 to 22 million by 2030.
18
 107 
Hence an understanding of the effects of macroeconomic changes on cancer outcomes worldwide is 108 
important. 109 
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 110 
We examined the association between changes in aggregate unemployment and PEH with deaths due to 111 
specific cancers, groups of cancers, and all cancers for countries where data was available and deemed 112 
of sufficient quality (1990–2010). Mortality was considered a more reliable measure of health outcomes 113 
than incidence due to the susceptibility of the latter to artificial rises following the adoption of improved 114 
means of diagnosis. We chose unemployment due to its ability to capture changes in individuals’ 115 
circumstances, especially in the lower-income strata of societies.
 
Given the recent drive, in many 116 
countries, to implement universal healthcare coverage (UHC),
19
 we explored whether UHC conferred a 117 
protective effect. We also estimated the difference between the actual numbers of cancer-related deaths 118 
during and after the recent economic downturn and the expected numbers based on prior trends. For 119 
convenience, we have used the term ‘excess deaths’ to denote those estimated differences for which the 120 
number of deaths was higher than expected. 121 
 122 
123 
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METHODS 124 
 125 
Data sources 126 
Economic data were obtained from the World Bank’s Development Indicators & Global Development 127 
Finance 2013 edition datasets.
20 
Unemployment (World Bank data code: SL.UEM.TOTL.ZS) was 128 
defined as the share of the labour force without work but available and seeking employment.
20
 PEH 129 
(World Bank data code: SH.XPD.PUBL.ZS) was measured as a percentage of gross domestic product 130 
(GDP) at purchasing power parity (PPP); it was defined by the World Bank as including all rent and 131 
capital spending from government budgets (central and local), external borrowings and grants 132 
(including donations from international agencies and non-governmental organisations), and social (or 133 
compulsory) health insurance funds. Unemployment and cancer mortality (see below) data for 1990 to 134 
2010 were available for 75 countries and data on PEH and cancer mortality for 1990 to 2009 were 135 
available for four additional countries (table 1), representing, as of 2009, 2.106 billion and 2.156 billion 136 
people in each dataset, respectively.
20
 Classification of countries into high- and middle-income was 137 
done according to the World Bank’s Atlas Method.21 In brief, middle-income countries are those with a 138 
gross national income per capita of more than $1 045 but less than $12 736, whereas high-income 139 
economies are those with a gross national income per capita of $12 736 or more. Countries were 140 
classified into those with very high or high human development indices (HDI) according to the UN’s 141 
Human Development Programme.
22
 142 
 143 
Cancer mortality data (deaths per 100 000) for 1990 to 2010 for the countries in the unemployment and 144 
PEH datasets were obtained from the World Health Organisation (WHO) mortality database.
23
 These 145 
data are based on death certification and updated annually from civil registration systems of WHO 146 
member states. Mortality data for prostate (ICD-10 C61), female-breast (ICD-10 C50), lung (male and 147 
female; ICD-10 C33–C34), colorectal (male and female; ICD-10 C18–C21) cancers and all cancers 148 
were extracted. Female breast, prostate and colorectal cancers have survival rates that exceed 50%.
24
 149 
Notably, at the time data were collected, complete cancer mortality data were unavailable for China, 150 
India, and countries from sub-Saharan Africa. We therefore aggregated the mortality data for these 151 
tumour types into a ‘treatable’ cancer class.  Lung and pancreatic cancers (male and female; ICD-10 152 
C25), which have five-year survival rates <10%, were likewise aggregated to give an ‘untreatable’ 153 
cancer category.
24
 Age-standardised death rates (ASDRs), accounting for age distribution differences in 154 
populations, were extracted for all ages and ages 0–84 for both sexes and each sex separately. For age-155 
specific cancer mortality rates, we aggregated crude rates (per 100 000 people) for each sex and country 156 
by 10-year age groups except for the youngest age group (0–34), which was combined to reduce the 157 
influence of age groups with fewer observations. These crude rates were defined as the number of 158 
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deaths during a calendar year for a particular age group divided by the age group’s mid-year population. 159 
 160 
Multivariable regression analysis 161 
We used multivariable regression analysis to assess the relationship between mortality rates for each 162 
cancer subtype, treatable cancers, untreatable cancers, and all cancers (response variable), and 163 
unemployment or PEH (predictor variable). Due to incomplete cancer mortality data for many of the 75 164 
countries in the unemployment dataset, observations for the year 2010 were excluded from the analysis. 165 
To ensure that results were not driven by uncontrollable inter-country variations, we used fixed effects 166 
in the regression models, including one dummy variable for each country in each dataset excluding a 167 
reference group (i.e. 74 dummy variables for the unemployment dataset and 78 for the PEH dataset; 168 
table 2). This meant that the regression models evaluated mortality changes within individual countries 169 
while holding constant time-invariant differences between countries, including higher predispositions to 170 
cancer as well as political, healthcare, cultural, and structural differences. Multivariable regression with 171 
fixed effects was used since this methodology has been widely employed in similar studies, and is 172 
regarded as statistically robust and conservative.
25
 The population structure of each country was also 173 
controlled for by incorporating total population size and demographic structure (the percentage of the 174 
population over 65 years and less than 15 years old) into the model (table 2). Further details of the 175 
model are provided in appendix S2. 176 
 177 
We conducted 1-, 2-, 3-, 4-, and 5-year time-lag analyses. For both datasets, we then classified countries 178 
into those with UHC and those without, and re-ran the analyses using UHC status as a robustness 179 
check. Countries were considered to have UHC if all of the following previously described criteria were 180 
met: legislation mandating UHC; >90% of the population with access to some form of healthcare 181 
insurance; and >90% of the population with access to skilled birth attendance. The latter criterion was 182 
used to ensure the implementation of UHC met minimum performance standards expected of a 183 
functioning healthcare system. To test the sensitivity of our results to this definition, we re-ran the 184 
analysis using an alternative performance criterion, details of which are included in appendix S1 in the 185 
Supplementary Material (table S1). Robustness checks are detailed in table 2 and appendix S2. 186 
 187 
Trend analysis 188 
For the all-cancer mortality trend projection analysis, we set strict country inclusion criteria to ensure 189 
that only high quality data were used. We therefore excluded countries with civil registration coverage 190 
of cause-of-death less than 90% for the study period,
23
 eliminating in the process 26 countries from the 191 
61 for which all-cancer mortality data were complete for 2000 to 2010 (figure 1). In order to limit the 192 
effect of miscoding and comorbidity (frequent for older population groups),
 
we excluded the 85+ age 193 
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group, and to further ensure robustness in cross-country comparisons, we excluded age groups with 194 
fewer than 20 deaths in any calendar year. Details of the models used are provided in appendix S3. 195 
 196 
Multivariable regression analyses were conducted using Stata SE version 12 (Stata Corporation, Texas, 197 
USA). Time-series analyses were conducted in R version 2.14.1 (http://www.r-project.org). 198 
 199 
Role of the funding source 200 
There was no funding source for this study. The corresponding author had full access to all the data in 201 
the study and had final responsibility for submitting the manuscript for publication. 202 
203 
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RESULTS 204 
 205 
Unemployment 206 
A 1% unemployment rise was associated with a statistically significant increase in mortality for all but 207 
one of the six cancer sub-types studied: prostate (regression coefficient (R)=0.0981, 95% CI 0.0353–208 
0.1609; p=0.0022), female-breast (R=0.1583, 95% CI 0.1110–0.2056; p<0.0001), male-lung 209 
(R=0.2260, 95% CI 0.1216–0.3304; p<0.0001), male-colorectal (R=0.0596, 95% CI 0.0188–0.1003; 210 
p=0.0042), and female-colorectal (R=0.0676, 95% CI 0.0362–0.099; p<0.0001) (figures 2A-E, figure 211 
S1A, table S2). The association for female-lung cancer mortality with unemployment was negative (R= 212 
–0.0593, 95% CI –0.1013 to 0.0172; p=0.0058; figure 2F, table S2). Whereas treatable cancer mortality 213 
was significantly linked with unemployment (R=0.1256, 95% CI 0.0148–0.2364; p=0.0265) (figure 2G, 214 
table S2), no such significance was observed for untreatable cancers (R=0.082, 95% CI -0.041–0.205; 215 
p=0.1919) (figure 2H, table S2). The strongest associations were found in the all-cancer data 216 
(R=0.3745, 95% CI 0.1939–0.5551; p=0.0001; figure 2I, table S2). Lag analysis showed that these 217 
results remained through to five years after unemployment increases (figure 2I). These associations held 218 
and remained significant in the robustness checks performed (tables S3–S9). 219 
 220 
On accounting for the UHC status of countries, we found no significant association between 221 
unemployment and cancer mortality within the first year of unemployment rising (table 3, figures S1B-222 
C). The results were unaffected by country classifications according to an alternative definition for 223 
UHC (appendix S1). 224 
 225 
Trend analysis 226 
For the trend analysis, population-weighted mean values of the projected age-specific rates and ASDRs 227 
for each year and sex were obtained. Globally (for the 35 countries selected), we observed significant 228 
deviations in the projected ASDR from the observed ASDR for both male all cancer mortality (figure 229 
3A, table S10) and female all cancer mortality (figure 3B, table S10) with the 2010 predicted ASDR – 3 230 
years after the unemployment rise in 2007 – deviating the most from the observed ASDR (males: rate 231 
ratio 1.0362, 95% CI 1.0209–1.052; p<0.0001; females: rate ratio 1.0428, 95% CI 1.0254–1.0607; 232 
p<0.0001). This corresponded to 55 434 (95% CI 32 439–78 428) excess deaths among men and 53 573 233 
(95% CI 32 386–74 759) excess deaths among women in 2010 alone. Summing the point estimates for 234 
males and females from 2008 to 2010 yielded 252,199 excess deaths (figure 3A). This finding was 235 
recapitulated upon confinement of our analysis to treatable cancers (rate ratio 1.0362, 95% CI 1.0225–236 
1.0502; p<0.0001; figure 3C, table S10) resulting in 22 977 (95% CI 14 482-31 472) excess deaths in 237 
2010. By contrast, for untreatable cancers, the deviation between predicted and observed ASDR was not 238 
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significant in 2008, 2009, or 2010 (figure 3D, table S10).  239 
 240 
We next asked whether these trends held among different groups of countries. To answer this, we 241 
extracted ASDRs for the following: 26 countries with UHC implemented and 9 countries without UHC 242 
as of 2008; 31 high-income countries and 4 middle-income countries as classified by the World Bank 243 
using the Atlas Method;
21
 and 22 very high HDI and 13 high HDI countries.
22
  244 
 245 
For the UHC country group, no significant difference was found for treatable cancer ASDR (figure 3E, 246 
table S10). By contrast, for the non-UHC country group the predicted ASDRs for treatable cancers were 247 
significantly lower than the observed ASDRs for all 3 projected years (in 2010: rate ratio 1.0746, 95% 248 
CI 1.0417–1.11; p<0.0001), which equated to 21 241 (95% CI 12 244–30 238) excess deaths due to 249 
treatable cancers in 2010 (figure 3F, table S10). Differences between the actual and projected ASDR of 250 
untreatable cancer were non-significant for both UHC and non-UHC country groups in 2008 with a 251 
significantly lower-than-expected number of deaths in 2009 and 2010 for the UHC country group, and a 252 
marginally significant higher-than-expected number of deaths in 2010 for the non-UHC country group 253 
(table S10).  254 
 255 
Stratifying countries by income using the World Bank’s classification,21 yielded higher rate ratios 256 
(indicating higher-than-expected numbers of deaths) for male, female and treatable cancers among 257 
middle-income countries than among high-income countries (table S10). For untreatable cancers, high-258 
income countries experienced significantly lower-than expected numbers of deaths whereas middle-259 
income countries experienced significantly higher-than-expected numbers of deaths (table S10). On 260 
dividing countries according to HDI, neither the very high nor high HDI groupings experienced higher-261 
than-expected numbers of untreatable cancer deaths although significantly lower-than expected 262 
numbers across all years were only observed for the very high HDI group (table S10).  263 
 264 
Public-sector expenditure on healthcare 265 
Increases in PEH, as a proportion of GDP, were significantly associated with mortality reductions in 266 
seven of the nine cancer categories studied: prostate (R= –0.0013, 95% CI –0.0019 to –0.0008; 267 
p<0.0001), female-breast (R= –0.0023, 95% CI –0.0029 to –0.0017; p<0.0001), male-lung (R= –268 
0.0037, 95% CI –0.0045 to –0.0028; p<0.0001), male-colorectal (R= –0.0011, 95% CI –0.0016 to –269 
0.0007; p<0.0001), female-colorectal (R= –0.0011, 95% CI –0.0014 to –0.0008; p<0.0001), treatable 270 
(R= –0.006858, 95% CI –0.007532 to –0.006184; p<0.0001) and all-cancers (R= –0.0053, 95% CI –271 
0.0070 to –0.0036; p<0.0001) (figure 4, table S11). Female-lung cancer mortality (R= 0.0007, 95% CI 272 
0.0004 to 0.0011; p=0.0001) on the other hand was significantly positively associated with PEH while 273 
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for mortality from untreatable cancers we observed no significant link (R= 0.0006, 95% CI –0.0002 to 274 
0.0014; p=0.1492) (figures 4F and 4H, table S11). 275 
  276 
Lag analysis showed that these results carried through to five years after increases in PEH (figure 4). 277 
Spending increases were associated with a slight increase in lung cancer mortality in women (figure 4F) 278 
but not at all with deaths from untreatable cancers (figure 4H). The same trends were found irrespective 279 
of UHC status (table 4). For the most part, these significant associations held in the robustness checks 280 
performed (tables S12–S18). 281 
 282 
283 
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DISCUSSION 284 
 285 
Our results suggest that increases in unemployment in 1990 to 2009 were associated with increased 286 
mortality of prostate, breast, male-lung, and colorectal cancers in a range of countries. Increases in 287 
unemployment were also associated with increased mortality due to a subset of treatable cancers as well 288 
as all cancers. Time-lag analyses indicated that these adverse effects persisted long after initial rises in 289 
unemployment. For the most part, these associations remained significant after controlling for 290 
economic, resource availability, infrastructure, and out-of-pocket spending indicators. UHC 291 
implementation, however, removed the association between changes in unemployment and cancer 292 
mortality implying that UHC could have had a protective effect against the possible impact of 293 
unemployment. Our findings also suggest that increased PEH (as a proportion of GDP) is associated 294 
with improved cancer mortality. This trend continued irrespective of UHC status. 295 
 296 
In all analyses, we could not demonstrate an association to female-lung cancer unlike other cancers 297 
(figures 2F and 4F). One plausible reason arising from our treatable versus untreatable cancer analysis 298 
is that this discrepancy might have been the consequence of the survival rate for female lung cancer 299 
being less than that for male; however, this hypothesis is not supported by evidence.
26
 As such, this 300 
remains a topic for future investigation.  301 
 302 
The trend analysis studied a particular set of periods in order to obtain counter-factual results for 2008–303 
2010 (the projection period), based on models of the mortality trends for 2000–2007 (the observation 304 
period), with the hypothesis that observation-period trends would continue for the projection period. 305 
These periods were chosen so as to correspond with the sharp upturn in unemployment observed from 306 
2008 onwards (figure S2) during the global economic crisis, while limiting the effects of previous 307 
unemployment fluctuations and technical progress in cancer care, which may otherwise have influenced 308 
rates if the observation period had been extended further back than 2000. We found the strongest, most 309 
significant deviations between observed and projected rates to occur for the non-UHC country 310 
grouping, corroborating our multivariable regression analyses. Likewise, the difference between 311 
expected and actual all-cancer mortality rates in middle-income countries exceeded that between high-312 
income countries, a finding that mirrors the variable influence that the income class of a country has on 313 
other causes of death.
27
 The chronological link between the unemployment rise due to the global 314 
economic crisis and the subsequent change in cancer mortality, lends favour to a potentially causal link, 315 
rather than reverse causality or endogeneity. 316 
 317 
The primary means by which increased unemployment is likely to have an adverse impact upon cancer 318 
13 
 
mortality is through reduced access to healthcare (figure 5), which may manifest as late-stage 319 
diagnoses,
28,29
 and poor or delayed treatment.
30
 Furthermore, unemployment has been found to correlate 320 
with lower socioeconomic status (SES).
31,32
 In turn, there is substantial evidence linking lower SES to 321 
lower cancer survival, with reduced access to treatment being a mediating cause,
33,34
 as well as lower 322 
health-seeking behaviours.
35
 Job loss is also strongly associated with mental health and behavioural 323 
problems,
5
 and this may also have a negative impact on survival in cancer patients as a consequence of 324 
lower rates of treatment commencement following diagnosis or higher treatment discontinuation rates.
36  
325 
 326 
Our results regarding PEH and cancer mortality are consistent with studies comparing spending levels 327 
across countries.
37
 Integrated multidisciplinary care pathways for cancer involving screening, 328 
radiotherapy, chemotherapy, and surgery, are costly but effective at reducing mortality. Changes in the 329 
availability of healthcare resources – whether at the diagnosis or treatment stage – due to changes in 330 
spending, are likely to have an impact on health outcomes. Additionally, further consequences of 331 
changes in PEH include changes in the number of healthcare professionals, with fewer healthcare 332 
professionals likely to result in reduced quality of care if productivity gains are not made,
38
 and changes 333 
in the number of localised sites providing healthcare, with longer distances or travel times likely to 334 
increase delays in presentation for diagnosis as well as adversely affect treatment.
39 
335 
 336 
Our study has  at least two major policy implications. First, it makes a strong case for UHC and its 337 
possible moderating effect on unemployed populations during economic downturns. In UHC countries 338 
where healthcare provision is meant to be equally accessible regardless of employment status, access to 339 
healthcare is less problematic than in non-UHC countries where access is often provided by means of 340 
an employment package. Second, amidst a background of rising healthcare costs, if spending 341 
restrictions are not accompanied by proportionate improvements in efficiency, worse quality of care 342 
and, in turn, higher mortality levels, may follow. 343 
 344 
We note several limitations of our study. First, we evaluated population health outcomes and economic 345 
trends but did not account for variations at regional and sub-national levels. Second, for reasons of data 346 
availability and quality, we were unable to analyse the effects of the global economic crisis after 2010. 347 
However, in addition to the sizeable economic fluctuations that occurred during the period studied, our 348 
analysis was still able to capture the effects of the earlier stages of the crisis with the trend analysis, 349 
during which unemployment levels rose sharply and in some countries peaked. For the PEH dataset, we 350 
did not account for changes in efficiency; indeed, it is possible that a country spends less on healthcare 351 
but achieves greater outcomes due to the efficiency of its system. Linked to this, we acknowledge the 352 
reduced global reach of our study due to the lack of data for low-income countries as well as China and 353 
14 
 
India. Indeed, an examination of whether our findings hold in lower income countries where it is 354 
possible that mortality rates for certain cancer types have been rising rather than falling would offer 355 
valuable insight. Fourth, our study was retrospective and observational, limiting our ability to draw 356 
causal inferences. The possibility of residual confounding from social determinant and region-specific 357 
healthcare system variables also necessitates a comprehensive, longitudinal approach characterising 358 
trends and predictors of healthcare access and quality before and after significant economic changes to 359 
strengthen the case for any causative effect as well as clarifying the expected latency between cancer 360 
treatment and mortality. Finally, by employing a fixed-effects model, we assumed that any unobserved 361 
factors within each country were time-invariant and not correlated with our variables of interest, 362 
although the comprehensiveness of our robustness checks will have reduced the probability of this 363 
assumption affecting our findings. 364 
 365 
Notwithstanding the limitations discussed, our findings suggest that both unemployment and PEH are 366 
significantly associated with cancer mortality, with associations lasting up to five years. We estimate 367 
that the 2008–2010 global economic crisis may have been associated with up to 250 000 excess cancer-368 
related deaths. Our analysis also suggests that UHC may remove the association between 369 
unemployment and cancer mortality, lending evidence in favour of healthcare system reforms aimed at 370 
providing UHC, particularly among middle-income countries. 371 
 372 
373 
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RESEARCH IN CONTEXT 496 
 497 
Evidence before this study 498 
We searched the literature to identify articles that quantitatively estimated either the effect of both 499 
unemployment and healthcare spending (public or otherwise) on cancer mortality, or the effect of 500 
universal healthcare coverage on cancer mortality. We searched PubMed for publications up to and 501 
including May 31 2015 using the following combinations of search terms: (i) unemployment AND 502 
cancer AND mortalit* AND (spending OR expenditure); (ii) cancer AND mortalit* AND ("universal 503 
health coverage" OR "universal healthcare coverage"). Search combination (i) yielded seven 504 
publications, and combination (ii) yielded one publication. With respect to search combination (i), 505 
 one study used a time-trend analysis to examine the relationship between unemployment and 506 
mortality in Scotland, and included specific causes of death such as lung cancer.
40
 A second study 507 
simply used Pearson’s correlation rather than a panel-based fixed effects model to find an association 508 
between all-cancer mortality, and healthcare expenditure (negative) and unemployment (positive) in 509 
European countries.
41
 The authors were therefore unable to control for potential confounding variables. 510 
The study periods for both these publications ended before the 2008 economic recession. Three further 511 
studies investigated a substantially narrower geographical region and outcome than the present study. 512 
The first study examined the relationship between spending, unemployment and breast cancer mortality 513 
in the European Union only,
14
 the second examined the relationship between unemployment and 514 
stomach cancer mortality again in the European Union only,
15
 while the third examined prostate cancer 515 
mortality in countries belonging to the Organisation for Economic Co-operation and Development.
42
 516 
The remaining two studies were not considered relevant, as they did not quantify the relationship 517 
between the macroeconomic indicators and cancer mortality. The study extracted from search 518 
combination (ii) was also irrelevant in that again it did not seek to quantify the influence of coverage on 519 
mortality. 520 
  521 
Added value of this study 522 
The study presented here is the first global analysis of the impact of unemployment and public 523 
healthcare spending on mortality due to all cancers, “treatable” cancers, “untreatable” cancers and 524 
specific forms of cancer. In using a conservative, fixed-effects regression analysis model to ascertain 525 
the existence of an association and quantify any associations combined with robustness checks, this 526 
study accounts for criticisms levelled at other studies looking at the relationship between health 527 
outcomes and unemployment, namely, the omission of potential confounding variables likely to be 528 
correlated with both unemployment rates (or public healthcare spending) and cancer mortality rates. In 529 
using a panel-data approach for the multivariable regression analysis to compare unemployment rates 530 
20 
 
(or public healthcare spending) at intervals of one year for each year after the increase in unemployment 531 
(or public healthcare spending) with the mortality rates in each country, we controlled for time-invariant 532 
heterogeneity between countries. Finally, we combined the above with a time-trend analysis, to provide 533 
a rigorous characterisation of the associations between unemployment, public healthcare spending, 534 
universal healthcare coverage, income, and cancer mortality. The major findings from these 535 
complementary approaches are that unemployment increases are associated with rises in cancer 536 
mortality, with universal healthcare coverage protecting against this phenomenon. Consideration of 537 
certain types of cancer as either treatable or untreatable revealed that significantly higher-than-expected 538 
numbers of deaths were only observed for treatable cancers. In contrast to unemployment, public 539 
healthcare spending increases are associated with reductions in cancer mortality with a recapitulation of 540 
the divergent findings between treatable and untreatable cancers. Whether or not a country has 541 
implemented universal healthcare coverage does not significantly alter the strength of this relationship. 542 
 543 
Implications of all the available evidence 544 
Policies that maintain spending and hence access to and quality of healthcare in the face of economic 545 
downturns especially among cancers that are considered treatable may offset some of the negative 546 
effects of such periods on health outcomes. Furthermore, the findings of our study add to the existing 547 
body of evidence in favour of universal healthcare coverage. 548 
549 
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FIGURE LEGENDS  550 
 551 
Figure 1. Cohort selection diagram for the trend prediction analysis 552 
Cohort selection with final aggregation by UHC status. The first step involves selecting only those 553 
countries with complete consecutive mortality data from 2000 to 2010. The second filters out countries 554 
with civil registration coverage of cause-of-death of <90%. Next, the over-85 age group and age groups 555 
with fewer than 20 deaths in any calendar year were excluded. The first row of boxes at the end of the 556 
workflow shows the categorisation of countries by UHC status (as determined by skilled birth 557 
attendance). The second row of boxes at the end of the workflow shows the categorisation of countries 558 
by income status. The third row shows the categorisation of countries by HDI. Cancer mortality data 559 
(deaths per 100 000) were obtained from the World Health Organisation Mortality Database 2013.
23
 560 
HDI categories were obtained from the United Nations Development Programme website.
22
 HDI, 561 
Human development index, UHC, Universal healthcare coverage.  562 
 563 
Figure 2. Time-lag analyses of changes in unemployment on cancer mortality. 564 
Multivariable regression analysis was conducted on data for 75 countries from 1990 to 2009 to assess 565 
the relationship between unemployment, and prostate cancer mortality (A), breast cancer mortality (B), 566 
male colorectal cancer mortality (C), female colorectal cancer mortality (D), male lung cancer mortality 567 
(E), female lung cancer mortality (F), treatable cancer mortality (G), untreatable cancer mortality (H) 568 
and all-cancer mortality (I). Analyses were conducting with controls for population size, population 569 
structure (proportion of population below 14 years of age and above 65 years of age), and country-570 
specific differences in healthcare infrastructure. Data are also shown for 1-, 2-, 3-, 4-, and 5-year time-571 
lag analyses. Economic data were obtained from the World Bank.
25
 Cancer mortality data (deaths per 572 
100 000) were obtained from the World Health Organisation Mortality Database 2013.
 23
 * p<0.05; ** 573 
p<0.01; *** p<0.001. 574 
 575 
Figure 3. Predicted cancer-related mortality rate and number of deaths, 2008–2010, based on 576 
2000–2007 observation base. 577 
Projections of age-standardised cancer-related mortality rates per 100 000 (ASDR) for 35 countries 578 
from 2008 to 2010 were made based upon ASDRs observed from 2000 to 2007, and compared with 579 
those observed from 2008 to 2010. The number of excess deaths due to male cancers (A), female 580 
cancers (B), treatable cancers (female breast, prostate and colorectal) (C), and untreatable cancers (lung 581 
and pancreatic) (D) were estimated by comparing 2008-2010 projected rates with 2008-2010 observed 582 
rates. The projections of ASDRs for treatable cancers are also shown for UHC (E) and non-UHC (F) 583 
22 
 
countries. ASDRs were extracted from the World Health Organisation Mortality Database 2013.
23 
* 584 
p<0.05; ** p<0.01; *** p<0.001.
 
585 
 586 
Figure 4. Time-lag analyses of changes in public-sector healthcare expenditure on cancer 587 
mortality. 588 
Multivariable regression analysis was conducted on data for 79 countries from 1990 to 2009 to assess 589 
the relationship between public-sector healthcare expenditure, and prostate cancer mortality (A), breast 590 
cancer mortality (B), male colorectal cancer mortality (C), female colorectal cancer mortality (D), male 591 
lung cancer mortality (E), female lung cancer mortality (F), treatable cancer mortality (G), untreatable 592 
cancer mortality (H), and all-cancer mortality (I). Analyses were conducted with controls for population 593 
size, population structure (proportion of population below 14 years of age and above 65 years of age), 594 
and country-specific differences in healthcare infrastructure. Data are also shown for 1-, 2-, 3-, 4-, and 595 
5-year time-lag analyses. Economic data were obtained from the World Bank.
25
 Cancer mortality data 596 
(deaths per 100 000) were obtained from the World Health Organisation Mortality Database 2013.
23
 * 597 
p<0.05; ** p<0.01; *** p<0.001. 598 
 599 
Figure 5. Possible causal pathways for the observed associations 600 
PEH, Public-sector expenditure on healthcare; SES, Socioeconomic status.  601 
602 
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TABLES 603 
Country/Grouping Population 2009 Country/Grouping 
Population 
2009 
Albania 3 151 185 Luxembourg 497 783 
Argentina 40 023 641 Macedonia 2 100 558 
Armenia 2 968 154 Malta 413 991 
Australia 21 778 800 Mauritius 1 275 032 
Austria 8 365 275 Mexico 116 815 612  
Azerbaijan 8 947 243 Moldova 3 565 603 
Barbados 279 006 Netherlands 16 530 388 
Belgium 10 796 493 New Zealand 4 315 800 
Belize 301 016 Nicaragua 5 743 329 
Brazil 193 490 922 Norway 4 828 726 
Bulgaria 7 585 131 Panama 3 615 846 
Canada 33 726 915 Paraguay 6 347 383 
Chile 16 991 729 Peru 28 934 303 
Colombia 45 802 561 Philippines 91 886 400 
Costa Rica 4 601 424 Poland 38 151 603 
Croatia 4 429 000 Portugal 10 632 482 
Cuba 11 288 826 Romania 21 480 401 
Czech Republic 10 487 178 Russian Federation 141 910 000 
Denmark 5 523 095 Serbia 7 320 807 
Dominican Republic 9 884 265 Singapore 4 987 600 
Ecuador 14 756 424 Slovak Republic 5 418 590 
Egypt 76 775 023 Slovenia 2 039 669 
El Salvador 6 183 484 Spain 45 908 594 
Estonia 1 340 271 Suriname 520 173 
Finland 5 338 871 Sweden 9 298 515 
France 64 702 921 Switzerland 7 743 831 
Georgia 4 410 900 Tajikistan 7 447 396 
Germany 81 902 307 Thailand 66 277 335 
Greece 11 282 760 Trinidad and Tobago 1 322 518 
Guatemala 13 988 988 Turkmenistan 4 978 962 
Hungary 10 022 650 Ukraine 46 053 300 
Iceland 318 499 United Kingdom 61 811 027 
Republic of Ireland 4 458 942 United States 306 771 529 
Israel 7 485 600 Uruguay 3 360 431 
Italy 60 192 698 Uzbekistan 27 767 400 
Japan 127 557 958 Venezuela 28 583 040 
Kazakhstan 16 093 481 High-income 1 066 391 720 
Republic of Korea 49 182 000 Middle-income  188 342 304 
Kuwait 2 850 102 UHC 641 437 562 
Kyrgyz Republic 5 383 300 Non-UHC 613 296 462 
Latvia 2 254 834 Very high human development index 849 195 806 
Lithuania 3 339 456 High human development index 405 538 218 
Table 1: Population estimates of countries included in multiple regression and time-series 605 
analyses, 2009. Population estimates were obtained from the World Bank (data code: 606 
SP.POP.TOTL).
20 
For country groupings, populations are calculated only for those countries 607 
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included in the time-series analysis as per figure 1. UHC, Universal healthcare coverage.608 
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 609 
 610 
 Table 2: Controls used in multiple regression and sensitivity analyses. Data were obtained from 611 
the World Bank.
 20 
PEH, Public-sector expenditure on healthcare. 612 
613 
 Common controls 
Robustness check 
control 
Particular control 
Total number of 
controls 
Unemploym
ent dataset 
(75 
countries) 
Population size 
 
Proportion of 
population less than 
15 years of age 
 
Proportion of 
population over 65 
years of age 
 
Economic 
Inflation 
GDP per capita changes 
Base interest rates 
80 
Resource availability 
Number of physicians per 
100 000 population; 
Number of hospital beds per 
100 000 population 
79 
Infrastructure 
Urbanisation; 
Access to water; 
Calorie intake 
80 
Out-of-pocket spending Out-of-pocket expenditure 78 
WHO data quality 
check 
N/A 
(Re-run analysis using data 
classified as Level 1 or 
Level 2 in quality by the 
WHO) 
77 
Income 
(2 categories coded into 1 
dummy variable) 
78 
Human development 
index 
(3 categories coded into 2 
dummy variables) 
79 
PEH dataset 
(79 
countries) 
Population size 
 
Proportion of 
population less than 
15 years of age 
 
Proportion of 
population over 65 
years of age 
 
Economic 
Inflation; 
GDP per capita changes; 
Base interest rates 
84 
Resource availability 
Number of physicians per 
100 000 population; 
Number of hospital beds per 
100 000 population 
83 
Infrastructure 
Urbanisation; 
Access to water; 
Calorie intake 
84 
Out-of-pocket spending Out-of-pocket expenditure 82 
WHO data quality 
check 
N/A 
(Re-run analysis using data 
classified as Level 1 or 
Level 2 in quality by the 
WHO) 
81 
Income 
(2 categories coded into 1 
dummy variable) 
82 
Human development 
index 
(3 categories coded into 2 
dummy variables) 
83 
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 614 
Table 3: Unemployment and cancer mortality rates controlling for universal healthcare coverage. 615 
Countries were classified as universal healthcare coverage (UHC) countries according to whether they 616 
were assessed to have met all of the following previously described conditions: legislation mandating 617 
UHC; >90% healthcare coverage; and >90% skilled birth attendance. 618 
619 
Cancer mortality in 
year of 
unemployment rise 
(deaths per 100 000) 
Co-efficient 
Robust 
standard error 
p Value 
Lower 
confidence 
interval (95%) 
Upper 
confidence 
interval (95%) 
Prostate cancer 0.0975 (0.1025) 0.3422 –0.1042 0.2992 
Breast (female) 
cancer 
0.0802 (0.0763) 0.2939 –0.0699 0.2302 
Colorectal (male) 
cancer 
–0.0679 (0.0589) 0.2495 –0.1838 0.0479 
Colorectal (female) 
cancer 
–0.0306 (0.0384) 0.4263 –0.1062 0.0450 
Lung (male) cancer –0.0126 (0.1753) 0.9428 –0.3575 0.3324 
Lung (female) 
cancer 
–0.0143 (0.0454) 0.7534 –0.1035 0.0750 
Treatable cancers 0.0319 (0.0692) 0.6449 –0.1037 0.1675 
Untreatable cancers 0.0758 (0.061) 0.2142 -0.0437 0.1952 
All cancers 0.0525 (0.1778) 0.7679 –0.2970 0.4019 
27 
 
 620 
 621 
Table 4: PEH and cancer mortality rates controlling for universal healthcare coverage. 622 
Countries were classified as universal healthcare coverage (UHC) countries according to whether 623 
they were assessed to have met all of the following previously described conditions: legislation 624 
mandating UHC; >90% healthcare coverage; and >90% skilled birth attendance. PEH, Public-625 
sector expenditure on healthcare. * p<0.05; ** p<0.01; *** p<0.001 626 
 627 
Cancer mortality in 
year of PEH rise 
(deaths per 100 000) 
Co-efficient 
Robust 
standard error 
p Value 
Lower 
confidence 
interval (95%) 
Upper 
confidence 
interval (95%) 
Prostate cancer –0.0009 (0.0001) 1.052×10
-10
*** –0.0011 –0.0006 
Breast (female) 
cancer 
–0.0009 (0.0001) 1.013×10-10*** –0.0012 –0.0007 
Colorectal (male) 
cancer 
–3×10-5 (0.0003) 0.9126 –0.0006 0.0006 
Colorectal (female) 
cancer 
–0.0004 (0.0001) 1.04×10-5*** –0.0011 –0.0002 
Lung (male) cancer –0.0007 (0.0003) 0.0087** –0.0012 –0.0002 
Lung (female) 
cancer 
0.0005 (0.0001) 2.19×10
-5
*** 0.0003 0.0007 
Treatable cancers –0.0022 (0.0005) 8.074×10
-6
*** –0.0032 –0.0012 
Untreatable cancers 0.0008 (0.0004) 0.0341* 0.0001 0.0016 
All cancers –0.0016 (0.0005) 1.7×10
-6
*** –0.0026 –0.0006 
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SUMMARY 35 
 36 
Background 37 
The global economic crisis has been associated with increased unemployment and reduced public-38 
sector expenditure on healthcare (PEH). We estimated the effects of changes in unemployment and PEH 39 
on cancer mortality, and identified how universal healthcare coverage (UHC) influenced the change. 40 
 41 
Methods 42 
Data were obtained from the World Bank and WHO (1990–2010). Mortality data from female breast, 43 
prostate and colorectal cancers, which have survival rates that exceed 50%, were aggregated into a 44 
‘treatable’ cancer class.  Lung and pancreatic cancers, which have five-year survival rates <10%, were 45 
likewise aggregated to give an ‘untreatable’ cancer category. Multivariable regression analysis was 46 
used, controlling for country-specific demographics and infrastructure, with time-lag analyses and 47 
robustness checks to explore the relationship between unemployment and PEH on cancer mortality, 48 
with and without UHC. Trend analysis was used to project mortality rates based on trends prior to the 49 
sharp unemployment rise experienced by many countries fromin 2008 to 2010, and compare them with 50 
observed rates. 51 
 52 
Results 53 
Data were available for 75 countries (unemployment analysis) and 79 countries (PEH analysis). 54 
Unemployment rises were significantly associated with an increase in all-cancer mortality and all 55 
specific cancers save for female-lung cancer. Untreatable cancer mortality by contrast was not 56 
significantly linked with changes in unemployment. Lag analyses showed significant associations 57 
remained five years after unemployment increases for the treatable cancer class. Re-running analyses 58 
while accounting for UHC status removed the significant associations. All-cancer, treatable cancer and 59 
specific cancer mortalities significantly decreased as PEH increased. Associations held over a five-year 60 
period regardless of whether UHC was present. Time-series analysis found just over 40 000 estimated 61 
excess deaths due to a subset of treatable cancers from 2008-2010 based on 2000-2007 trends. The great 62 
majority of these deaths were from non-UHC countries. 63 
 64 
Interpretation 65 
Unemployment increases are associated with cancer mortality increases. There is evidence that UHC 66 
protects against mortality increases associated with rises in unemployment, while PEH increases are 67 
associated with reduced cancer mortality. Reduced access to healthcare may underlie these associations. 68 
 69 
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INTRODUCTION 76 
 77 
The global economic crisis, which began in 2008, compelled many countries to cut public spending in 78 
order to reduce public-sector borrowing.
1
 These spending cuts often entailed either reductions or a 79 
flattening in public-sector jobs and public-sector expenditure on healthcare (PEH).
2,3
 Indeed, 33Thirty 80 
three of 53 WHO European region countries underwent no change in PEH between 2008 and 2009, 81 
while six experienced a reduction in PEH,
4
 which have prompted concerns about the possible negative 82 
effects on public health. Studies have demonstrated that long-term unemployment leads to increased 83 
suicide rates and reduced healthcare access.
5,6
 84 
 85 
Ecological studies exploring health-economic trends in the short run (separate from residual or secular 86 
trends) have thus far focused on macroeconomic changes and outcome indicators, such as suicide rates, 87 
cardiovascular disease incidence, all-cause mortality and specific forms of cancer, but not cancer per 88 
se.
3,7–15
 These potential associations may predominantly be explained by behavioural, mental, or stress-89 
related changes with direct and immediate effects, whether, as in the case of suicides, they are counter-90 
cyclical associations linked to the direct psychological and financial impact of job loss,
16
 or pro-cyclical 91 
associations linked to reduced injury-related work and lifestyle activities in the case of all-cause 92 
mortality.
9
 Few studies, however, have analysed the relationship between economic downturns and 93 
cancer especially in countries that are may be more susceptible to economic shocks due to less-94 
developedimited social security and healthcare systems.  95 
 96 
Establishing a causal relationship between an economic change, such as aggregate unemployment, on 97 
cancer mortality is challenging, as downstream effects of unemployment-induced behavioural changes 98 
on lifestyle-related cancers manifest much later (20-30 years) than, for example, suicide or acute, stress-99 
related cardiovascular events. However, access to healthcare and PEH may act as mediating factors with 100 
more immediate effects on health outcomes. One study on the Great Depression found deaths from 101 
cancer correlated with reduced income,
17
 although the lack of treatment options for patients presenting 102 
with late-stage disease meant that the effect of the economic downturn on reduced healthcare access and 103 
mortality could not be as strongly demonstrated as it could in an era where systemic treatment is now 104 
available. 105 
 106 
Cancer is one of the leading causes of death worldwide, accounting for 8.2 million deaths in 2012, with 107 
estimates suggesting a rise in annual cancer cases from 14 million in 2012 to 22 million by 2030.
18
 108 
Hence an understanding of the effects of macroeconomic changes on cancer outcomes worldwide is 109 
important. 110 
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 111 
We examined the association between changes in aggregate unemployment and PEH with deaths due to 112 
specific cancers, groups of cancers, and all cancers for countries where data was available and deemed 113 
of sufficient quality (1990–2010). Mortality was considered a more reliable measure of health outcomes 114 
than incidence due to the susceptibility of the latter to artificial rises following the adoption of improved 115 
means of diagnosis. We chose unemployment due to its ability to capture changes in individuals’ 116 
circumstances, especially in lower-income strata of societies.
 
Given the recent drive, in many countries, 117 
to implement universal healthcare coverage (UHC),We explored whether universal healthcare coverage 118 
(UHC) conferred a protective effect, hypothesising that UHC would enable the unemployed to access 119 
healthcare, especially as many countries progress towards UHC systems.
19
 we explored whether UHC 120 
conferred a protective effect. We also estimated the difference between the actual numbers of cancer-121 
related deaths during and after the recent economic downturn and the expected numbers based on prior 122 
trends. For convenience, we have used the term ‘excess deaths’ to denote those estimated differences 123 
for which the number of deaths was higher than expected.We estimated additional cancer-related deaths 124 
due to the recent economic downturn. 125 
 126 
127 
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METHODS 128 
 129 
Data sources 130 
Economic data were obtained from the World Bank’s Development Indicators & Global Development 131 
Finance 2013 edition datasets.
20 
Unemployment (World Bank data code: SL.UEM.TOTL.ZS) was 132 
defined as the share of the labour force without work but available and seeking employment.
20
 PEH 133 
(World Bank data code: SH.XPD.PUBL.ZS) was measured as a percentage of gross domestic product 134 
(GDP) at purchasing power parity (PPP); it was defined by the World Bank as including all rent and 135 
capital spending from government budgets (central and local), external borrowings and grants 136 
(including donations from international agencies and non-governmental organisations), and social (or 137 
compulsory) health insurance funds. Unemployment and cancer mortality (see below) data for 1990 to 138 
2010 were available for 75 countries and data on PEH for 1990 to 2009 were available for four 139 
additional countries (table 1), representing, as of 2009, 2.106 billion and 2.156 billion people in each 140 
dataset, respectively.
20
 Classification of countries into high- and middle-income was done according to 141 
the World Bank’s Atlas Method.21 In brief, middle-income countries are those with a gross national 142 
income per capita of more than $1 045 but less than $12 736, whereas high-income economies are those 143 
with a gross national income per capita of $12 736 or more. Countries were classified into those with 144 
very high or high human development indices (HDI) according to the UN’s Human Development 145 
Programme.
22
 146 
 147 
Cancer mortality data (deaths per 100 000) for 1990 to 2010 for the countries in the unemployment and 148 
PEH datasets were obtained from the World Health Organisation (WHO) mortality database.
23
 These 149 
data are based on death certification and updated annually from civil registration systems of WHO 150 
member states. Mortality data for prostate (ICD-10 C61), female-breast (ICD-10 C50), lung (male and 151 
female; ICD-10 C33–C34), colorectal (male and female; ICD-10 C18–C21) cancers and all cancers 152 
were extracted. Female breast, prostate and colorectal cancers have survival rates that exceed 50%.
24
 153 
We therefore aggregated the mortality data for these tumour types into a ‘treatable’ cancer class.  Lung 154 
and pancreatic cancers (male and female; ICD-10 C25), which have five-year survival rates <10%, were 155 
likewise aggregated to give an ‘untreatable’ cancer category.24 Notably, at the time data were collected, 156 
complete cancer mortality data were unavailable for China, India, and countries from sub-Saharan 157 
Africa. Age-standardised death rates (ASDRs), accounting for age distribution differences in 158 
populations, were extracted for all ages and ages 0–84 for both sexes and each sex separately. For age-159 
specific cancer mortality rates, we aggregated crude rates (per 100 000 people) for each sex and country 160 
by 10-year age groups except for the youngest age group (0–34), which was combined to reduce the 161 
influence of age groups with fewer observations. These crude rates were defined as the number of 162 
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deaths during a calendar year for a particular age group divided by the age group’s mid-year population. 163 
 164 
Multivariable regression analysis 165 
We used multivariable regression analysis to assess the relationship between mortality rates for each 166 
cancer subtype, treatable cancers, untreatable cancers and all cancers (response variable), and 167 
unemployment or PEH (predictor variable). Due to incomplete cancer mortality data for many of the 75 168 
countries in the unemployment dataset, observations for the year 2010 were excluded from the analysis. 169 
To ensure that results were not driven by uncontrollable inter-country variations, we used fixed effects 170 
in the regression models, including one dummy variable for each country in each dataset excluding a 171 
reference group (i.e. 74 dummy variables for the unemployment dataset and 78 for the PEH dataset; 172 
table 2). This meant that the regression models evaluated mortality changes within individual countries 173 
while holding constant time-invariant differences between countries, including higher predispositions to 174 
cancer as well as political, healthcare, cultural, and structural differences. Multivariable regression with 175 
fixed effects was used since this methodology has been widely employed in similar studies, and is 176 
regarded as statistically robust and conservative.
25
 The population structure of each country was also 177 
controlled for by incorporating total population size and demographic structure (the percentage of the 178 
population over 65 years and less than 15 years old) into the model (table 2). Further details of the 179 
model are provided in appendix S2. 180 
 181 
We conducted 1-, 2-, 3-, 4-, and 5-year time-lag analyses. For both datasets, we then classified countries 182 
into those with UHC and those without, and re-ran the analyses using UHC status as a robustness 183 
check. Countries were considered to have UHC if all of the following previously described criteria were 184 
met: legislation mandating UHC; >90% of the population with access to some form of healthcare 185 
insurance; and >90% of the population with access to skilled birth attendance. The latter criterion was 186 
used to ensure the implementation of UHC met minimum performance standards expected of a 187 
functioning healthcare system. To test the sensitivity of our results to this definition, we re-ran the 188 
analysis using an alternative performance criterion, details of which are included in appendix S1 in the 189 
Supplementary Material (table S1). Robustness checks are detailed in table 2 and appendix S2. 190 
 191 
Trend analysis 192 
For the all-cancer mortality trend projection analysis, we set strict country inclusion criteria to ensure 193 
that only high quality data were used. We therefore excluded countries with civil registration coverage 194 
of cause-of-death less than 90% for the study period,
23
 eliminating in the process 26 countries from the 195 
61 for which all-cancer mortality data were complete for 2000 to 2010 (figure 1). In order to limit the 196 
effect of miscoding and comorbidity (frequent for older population groups),
 
we excluded the 85+ age 197 
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group, and to further ensure robustness in cross-country comparisons, we excluded age groups with 198 
fewer than 20 deaths in any calendar year. Details of the models used are provided in appendix S3. 199 
 200 
Multivariable regression analyses were conducted using Stata SE version 12 (Stata Corporation, Texas, 201 
USA). Time-series analyses were conducted in R version 2.14.1 (http://www.r-project.org). 202 
 203 
Role of the funding source 204 
There was no funding source for this study. The corresponding author had full access to all the data in 205 
the study and had final responsibility for submitting the manuscript for publication. 206 
207 
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RESULTS 208 
 209 
Unemployment 210 
A 1% unemployment rise was associated with a statistically significant increase in mortality for all but 211 
one of the six cancer sub-types studied: prostate (regression coefficient (R)=0.0981, 95% CI 0.0353–212 
0.1609; p=0.0022), female-breast (R=0.1583, 95% CI 0.1110–0.2056; p<0.0001), male-lung 213 
(R=0.2260, 95% CI 0.1216–0.3304; p<0.0001), male-colorectal (R=0.0596, 95% CI 0.0188–0.1003; 214 
p=0.0042), and female-colorectal (R=0.0676, 95% CI 0.0362–0.099; p<0.0001) (figures 2A-E, figure 215 
S1A, table S2). The association for female-lung cancer mortality with unemployment was negative (R= 216 
–0.0593, 95% CI –0.1013 to 0.0172; p=0.0058; figure 2F, table S2). Whereas treatable cancer mortality 217 
was significantly linked with unemployment (R=0.1256, 95% CI 0.0148–0.2364; p=0.0265) (figure 2G, 218 
table S2), no such significance was observed for untreatable cancers (R=0.082, 95% CI -0.041–0.205; 219 
p=0.1919) (figure 2H, table S2). The strongest associations were found in the all-cancer data 220 
(R=0.3745, 95% CI 0.1939–0.5551; p=0.0001; figure 2I, table S2). Lag analysis showed that these 221 
results remained through to five years after unemployment increases (figure 2I). These associations held 222 
and remained significant in the robustness checks performed (tables S3–S9). 223 
 224 
On accounting for the UHC status of countries, we found no significant association between 225 
unemployment and cancer mortality within the first year of unemployment rising (table 3, figures S1B-226 
C). The results were unaffected by country classifications according to an alternative definition for 227 
UHC (appendix S1). 228 
 229 
Trend analysis 230 
For the trend analysis, population-weighted mean values of the projected age-specific rates and ASDRs 231 
for each year and sex were obtained. Globally (for the 35 countries selected), we observed significant 232 
deviations in the projected ASDR from the observed ASDR for both male all cancer mortality (figure 233 
3A, table S10) and female all cancer mortality (figure 3B, table S10) with the 2010 predicted ASDR – 3 234 
years after the unemployment rise in 2007 – deviating the most from the observed ASDR (males: rate 235 
ratio 1.0362, 95% CI 1.0209–1.052; p<0.0001; females: rate ratio 1.0428, 95% CI 1.0254–1.0607; 236 
p<0.0001). This corresponded to 55 434 (95% CI 32 439-78 428) excess deaths among men and 53 573 237 
(95% CI 32 386-74 759) excess deaths among women in 2010 alone . Summing the point estimates for 238 
males and females from 2008 to 2010 yielded 252 ,199 excess deaths (figure 3A)(figure 3A). This 239 
finding was recapitulated upon confinement of our analysis to treatable cancers (rate ratio 1.0362, 95% 240 
CI 1.0225–1.0502; p<0.0001; figure 3C, table S10) resulting in 22 977 (95% CI 14 482-31 472) excess 241 
deaths in 2010. By contrast, for untreatable cancers, the deviation between predicted and observed 242 
10 
 
ASDR was not significant in 2008, 2009 or 2010 (figure 3D, table S10).  243 
 244 
We next asked whether these trends held among different groups of countries. To answer this, we 245 
extracted ASDRs for the following: 26 countries with UHC implemented and 9 countries without UHC 246 
as of 2008; 31 high-income countries and 4 middle-income countries as classified by the World Bank 247 
using the Atlas Method;
21
 and 22 very high HDI and 13 high HDI countries.
22
  248 
 249 
For the UHC country group, no significant difference was found for treatable cancer ASDR (figure 3E, 250 
table S10). By contrast, for the non-UHC country group the predicted ASDRs for treatable cancers were 251 
significantly lower than the observed ASDRs for all 3 projected years (in 2010: rate ratio 1.0746, 95% 252 
CI 1.0417–1.11; p<0.0001), which equated to 21 241 (95% CI 12 244-30 238) excess deaths due to 253 
treatable cancers in 2010 (figure 3F, table S10). Differences between the actual and projected ASDR of 254 
untreatable cancer were non-significant for both UHC and non-UHC country groups in 2008 with a 255 
significantly lower-than-expected number of deaths in 2009 and 2010 for the UHC country group, and a 256 
marginally significant higher-than-expected number of deaths in 2010 for the non-UHC country group 257 
(table S10).  258 
 259 
Stratifying countries by income using the World Bank’s classification yielded higher rate ratios 260 
(indicating higher-than-expected numbers of deaths) for male, female and treatable cancers among 261 
middle-income countries than among high-income countries (table S10). For untreatable cancers, high-262 
income countries experienced significantly lower-than expected numbers of deaths whereas middle-263 
income countries experienced significantly higher-than-expected numbers of deaths (table S10). On 264 
dividing countries according to HDI, neither the very high nor high HDI groupings experienced higher-265 
than-expected numbers of untreatable cancer deaths although significantly lower-than expected 266 
numbers across all years were only observed for the very high HDI group (table S10).  267 
 268 
Public-sector expenditure on healthcare 269 
Increases in PEH, as a proportion of GDP, were significantly associated with mortality reductions in 270 
seven of the nine cancer categories studied: prostate (R= –0.0013, 95% CI –0.0019 to –0.0008; 271 
p<0.0001), female-breast (R= –0.0023, 95% CI –0.0029 to –0.0017; p<0.0001), male-lung (R= –272 
0.0037, 95% CI –0.0045 to –0.0028; p<0.0001), male-colorectal (R= –0.0011, 95% CI –0.0016 to –273 
0.0007; p<0.0001), female-colorectal (R= –0.0011, 95% CI –0.0014 to –0.0008; p<0.0001), treatable 274 
(R= –0.006858, 95% CI –0.007532 to –0.006184; p<0.0001) and all-cancers (R= –0.0053, 95% CI –275 
0.0070 to –0.0036; p<0.0001) (figure 4, table S11). Female-lung cancer mortality (R= 0.0007, 95% CI 276 
0.0004 to 0.0011; p=0.0001) on the other hand was significantly positively associated with PEH while 277 
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for mortality from untreatable cancers we observed no significant link (R= 0.0006, 95% CI –0.0002 to 278 
0.0014; p=0.1492) (figures 4F and 4H, table S11). 279 
  280 
Lag analysis showed that these results carried through to five years after increases in PEH (figure 4). 281 
Spending increases were associated with a slight increase in lung cancer mortality in women (figure 4F) 282 
but not at all with deaths from untreatable cancers (figure 4H). The same trends were found irrespective 283 
of UHC status (table 4). For the most part, these significant associations held in the robustness checks 284 
performed (tables S12–S18). 285 
 286 
287 
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DISCUSSION 288 
 289 
Our results suggest that increases in unemployment in 1990 to 2009 were associated with increased 290 
mortality of prostate, breast, male-lung, and colorectal cancers in a range of countries. Increases in 291 
unemployment were also associated with increased mortality due to a subset of treatable cancers as well 292 
as all cancers. Time-lag analyses indicated that these adverse effects persisted long after initial rises in 293 
unemployment. For the most part, these associations remained significant after controlling for 294 
economic, resource availability, infrastructure, and out-of-pocket spending indicators. UHC 295 
implementation, however, removed the association between changes in unemployment and cancer 296 
mortality implying that UHC could have had a protective effect against the possible impact of 297 
unemployment. Our findings also suggest that increased PEH (as a proportion of GDP) is associated 298 
with improved cancer mortality. This trend continued irrespective of UHC status. 299 
 300 
In all analyses, we could not demonstrate an association to female-lung cancer unlike other cancers 301 
(figures 2F and 4F). One plausible reason arising from our treatable versus untreatable cancer analysis 302 
is that this discrepancy might have been the consequence of the survival rate for female lung cancer 303 
being less than that for male; however, this hypothesis is not supported by evidence.
26
 As such, this 304 
remains a topic for future investigation.  305 
 306 
The trend analysis studied a particular set of periods in order to obtain counter-factual results for 2008–307 
2010 (the projection period), based on models of the mortality trends for 2000–2007 (the observation 308 
period), with the hypothesis that observation-period trends would continue for the projection period. 309 
These periods were chosen so as to correspond with the sharp upturn in unemployment observed from 310 
2008 onwards (figure S2) during the global economic crisis, while limiting the effects of previous 311 
unemployment fluctuations and technical progress in cancer care, which may otherwise have influenced 312 
rates if the observation period had been extended further back than 2000. We found the strongest, most 313 
significant deviations between observed and projected rates to occur for the non-UHC country 314 
grouping, corroborating our multivariable regression analyses. Likewise, the difference between 315 
expected and actual all-cancer mortality rates in middle-income countries exceeded that between high-316 
income countries, a finding that mirrors the variable influence that the income class of a country has on 317 
other causes of death.
27
 The chronological link between the unemployment rise due to the global 318 
economic crisis and the subsequent change in cancer mortality, lends favour to a potentially causal link, 319 
rather than reverse causality or endogeneity. 320 
 321 
The primary means by which increased unemployment is likely to have an adverse impact upon cancer 322 
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mortality is through reduced access to healthcare (figure 5), which may manifest as late-stage 323 
diagnoses,
28,29
 and poor or delayed treatment.
30
 Furthermore, unemployment has been found to correlate 324 
with lower socioeconomic status (SES).
31,32
 In turn, there is substantial evidence linking lower SES to 325 
lower cancer survival, with reduced access to treatment being a mediating cause,
33,34
 as well as lower 326 
health-seeking behaviours.
35
 Job loss is also strongly associated with mental health and behavioural 327 
problems,
5
 and this may also have a negative impact on survival in cancer patients as a consequence of 328 
lower rates of treatment commencement following diagnosis or higher treatment discontinuation rates.
36  
329 
 330 
Our results regarding PEH and cancer mortality are consistent with studies comparing spending levels 331 
across countries.
37
 Integrated multidisciplinary care pathways for cancer involving screening, 332 
radiotherapy, chemotherapy, and surgery, are costly but effective at reducing mortality. Changes in the 333 
availability of healthcare resources – whether at the diagnosis or treatment stage – due to changes in 334 
spending, are likely to have an impact on health outcomes. Additionally, further consequences of 335 
changes in PEH include changes in the number of healthcare professionals, with fewer healthcare 336 
professionals likely to result in reduced quality of care if productivity gains are not made,
38
 and changes 337 
in the number of localised sites providing healthcare, with longer distances or travel times likely to 338 
increase delays in presentation for diagnosis as well as adversely affect treatment.
39 
339 
 340 
Our study has three at least two major policy implications. First, it makes a strong case for UHC and its 341 
possible moderating effect on unemployed populations during economic downturns. In UHC countries 342 
where healthcare provision is meant to be equally accessible regardless of employment status, access to 343 
healthcare is less problematic than in non-UHC countries where access is often provided by means of 344 
an employment package. Second, fiscal consolidation measures introduced during the economic crisis 345 
are likely exacerbating the adverse health effects of the global economic downturn rather than 346 
ameliorating them. Some have advocated that to reduce adverse effects, government policy should seek 347 
to actively maintain aggregate employment levels;
25
 the implication being that, from a public-health 348 
perspective, expansionary fiscal policy is the optimal response to the slumps in aggregate demand and 349 
concomitant private-sector unemployment seen during economic downturns. Similarly, it is reasonable 350 
to propose that if governments fail not just to maintain PEH but also to maintain levels of total 351 
healthcare expenditure by not compensating for reduced private-sector and private-household spending 352 
in economic crises, then there may be considerable adverse consequences for public health. Third, 353 
amidst a background of rising healthcare costs, if spending restrictions are not accompanied by 354 
proportionate improvements in efficiency, worse quality of care and, in turn, higher mortality levels, 355 
may follow. 356 
 357 
14 
 
We note several limitations of our study. First, we evaluated population health outcomes and economic 358 
trends but did not account for variations at regional and sub-national levels. Second, for reasons of data 359 
availability and quality, we were unable to analyse the effects of the global economic crisis after 2010. 360 
However, in addition to the sizeable economic fluctuations that occurred during the period studied, our 361 
analysis was still able to capture the effects of the earlier stages of the crisis with the trend analysis, 362 
during which unemployment levels rose sharply and in some countries peaked. For the PEH dataset, we 363 
did not account for changes in efficiency; indeed, it is possible that a country spends less on healthcare 364 
but achieves greater outcomes due to the efficiency of its system. Linked to this, we acknowledge the 365 
reduced global reach of our study due to the lack of data for low-income countries as well as China and 366 
India. Indeed, an examination of whether our findings hold in lower income countries where it is 367 
possible that mortality rates for certain cancer types have been rising rather than falling would offer 368 
valuable insight. Fourth, our study was retrospective and observational, limiting our ability to draw 369 
causal inferences. The possibility of residual confounding from social determinant and region-specific 370 
healthcare system variables also necessitates a comprehensive, longitudinal approach characterising 371 
trends and predictors of healthcare access and quality before and after significant economic changes to 372 
strengthen the case for any causative effect as well as clarifying the expected latency between cancer 373 
treatment and mortality. Finally, by employing a fixed-effects model, we assumed that any unobserved 374 
factors within each country were time-invariant and not correlated with our variables of interest, 375 
although the comprehensiveness of our robustness checks will have reduced the probability of this 376 
assumption affecting our findings. 377 
 378 
Notwithstanding the limitations discussed, our findings suggest that both unemployment and PEH are 379 
significantly associated with cancer mortality, with associations lasting up to five years. We estimate 380 
that the 2008–2010 global economic crisis may have been associated with up to 100 250 000 additional 381 
excess cancer-related deaths. Our analysis also suggests that UHC may removes the association 382 
between unemployment and cancer mortality, lending evidence in favour of healthcare system reforms 383 
aimed at providing UHC, particularly among middle-income countries. 384 
 385 
386 
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RESEARCH IN CONTEXT 509 
 510 
Evidence before this study 511 
We searched the literature to identify articles that quantitatively estimated either the effect of both 512 
unemployment and healthcare spending (public or otherwise) on cancer mortality, or the effect of 513 
universal healthcare coverage on cancer mortality. We searched PubMed for publications up to and 514 
including May 31 2015 using the following combinations of search terms: (i) unemployment AND 515 
cancer AND mortalit* AND (spending OR expenditure); (ii) cancer AND mortalit* AND "universal 516 
healthcare coverage". Search combination (i) yielded seven publications, and combination (ii) yielded 517 
one publication. With respect to search combination (i),  one study used a time-trend analysis to 518 
examine the relationship between unemployment and mortality in Scotland, and included specific 519 
causes of death such as lung cancer.
40
 A second study simply used Pearson’s correlation rather than a 520 
panel-based fixed effects model to find an association between all-cancer mortality, and healthcare 521 
expenditure (negative) and unemployment (positive) in European countries.
41
 The authors were 522 
therefore unable to control for potential confounding variables. The study periods for both these 523 
publications ended before the 2008 economic recession. Three further studies investigated a 524 
substantially narrower geographical region and outcome than the present study. The first study 525 
examined the relationship between spending, unemployment and breast cancer mortality in the 526 
European Union only,
14
 the second examined the relationship between unemployment and stomach 527 
cancer mortality again in the European Union only,
15
 while the third examined prostate cancer mortality 528 
in countries belonging to the Organisation for Economic Co-operation and Development.
42
 The 529 
remaining two studies were not considered relevant, as they did not quantify the relationship between 530 
the macroeconomic indicators and cancer mortality. The study extracted from search combination (ii) 531 
was also irrelevant in that again it did not seek to quantify the influence of coverage on mortality. 532 
  533 
Added value of this study 534 
The study presented here is the first global analysis of the impact of unemployment and public 535 
healthcare spending on mortality due to all cancers, “treatable” cancers, “untreatable” cancers and 536 
specific forms of cancer. In using a conservative, fixed-effects regression analysis model to ascertain 537 
the existence of an association and quantify any associations combined with robustness checks, this 538 
study accounts for criticisms levelled at other studies looking at the relationship between health 539 
outcomes and unemployment, namely, the omission of potential confounding variables likely to be 540 
correlated with both unemployment rates (or public healthcare spending) and cancer mortality rates. In 541 
using a panel-data approach for the multivariable regression analysis to compare unemployment rates 542 
(or public healthcare spending) at intervals of one year for each year after the increase in unemployment 543 
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(or public healthcare spending) with the mortality rates in each country, we controlled for time-invariant 544 
heterogeneity between countries. Finally, we combined the above with a time-trend analysis, to provide 545 
a rigorous characterisation of the associations between unemployment, public healthcare spending, 546 
universal healthcare coverage, income, and cancer mortality. The major findings from these 547 
complementary approaches are that unemployment increases are associated with rises in cancer 548 
mortality, with universal healthcare coverage protecting against this phenomenon. Consideration of 549 
certain types of cancer as either treatable or untreatable revealed that significantly higher-than-expected 550 
numbers of deaths were only observed for treatable cancers. In contrast to unemployment, public 551 
healthcare spending increases are associated with reductions in cancer mortality with a recapitulation of 552 
the divergent findings between treatable and untreatable cancers. Whether or not a country has 553 
implemented universal healthcare coverage does not significantly alter the strength of this relationship. 554 
 555 
Implications of all the available evidence 556 
Policies that maintain spending and hence access to and quality of healthcare in the face of economic 557 
downturns especially among cancers that are considered treatable may offset some of the negative 558 
effects of such periods on health outcomes. Furthermore, the findings of our study add to the existing 559 
body of evidence in favour of universal healthcare coverage. 560 
561 
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FIGURE LEGENDS  562 
 563 
Figure 1. Cohort selection diagram for the trend prediction analysis 564 
Cohort selection with final aggregation by UHC status. The first step involves selecting only those 565 
countries with complete consecutive mortality data from 2000 to 2010. The second filters out countries 566 
with civil registration coverage of cause-of-death of <90%. Next, the over-85 age group and age groups 567 
with fewer than 20 deaths in any calendar year were excluded. The first row of boxes at the end of the 568 
workflow shows the categorisation of countries by UHC status (as determined by skilled birth 569 
attendance). The second row of boxes at the end of the workflow shows the categorisation of countries 570 
by income status. The third row shows the categorisation of countries by HDI. Cancer mortality data 571 
(deaths per 100 000) were obtained from the World Health Organisation Mortality Database 2013.
23
 572 
HDI categories were obtained from the United Nations Development Programme website.
22
 HDI, 573 
Human development index, UHC, Universal healthcare coverage.  574 
 575 
Figure 2. Time-lag analyses of changes in unemployment on cancer mortality. 576 
Multivariable regression analysis was conducted on data for 75 countries from 1990 to 2009 to assess 577 
the relationship between unemployment, and prostate cancer mortality (A), breast cancer mortality (B), 578 
male colorectal cancer mortality (C), female colorectal cancer mortality (D), male lung cancer mortality 579 
(E), female lung cancer mortality (F), treatable cancer mortality (G), untreatable cancer mortality (H) 580 
and all-cancer mortality (I). Analyses were conducting with controls for population size, population 581 
structure (proportion of population below 14 years of age and above 65 years of age), and country-582 
specific differences in healthcare infrastructure. Data are also shown for 1-, 2-, 3-, 4-, and 5-year time-583 
lag analyses. Economic data were obtained from the World Bank.
25
 Cancer mortality data (deaths per 584 
100 000) were obtained from the World Health Organisation Mortality Database 2013.
 23
 * p<0.05; ** 585 
p<0.01; *** p<0.001. 586 
 587 
Figure 3. Predicted cancer-related mortality rate and number of deaths, 2008–2010, based on 588 
2000–2007 observation base. 589 
Projections of age-standardised cancer-related mortality rates per 100 000 (ASDR) for 35 countries 590 
from 2008 to 2010 were made based upon ASDRs observed from 2000 to 2007, and compared with 591 
those observed from 2008 to 2010. The number of excess deaths due to male cancers (A), female 592 
cancers (B), treatable cancers (female breast, prostate and colorectal) (C), and untreatable cancers (lung 593 
and pancreatic) (D) were estimated by comparing 2008-2010 projected rates with 2008-2010 observed 594 
rates. The projections of ASDRs for treatable cancers are also shown for UHC (E) and non-UHC (F) 595 
22 
 
countries. ASDRs were extracted from the World Health Organisation Mortality Database 2013.
23 
* 596 
p<0.05; ** p<0.01; *** p<0.001.
 
597 
 598 
Figure 4. Time-lag analyses of changes in public-sector healthcare expenditure on cancer 599 
mortality. 600 
Multivariable regression analysis was conducted on data for 79 countries from 1990 to 2009 to assess 601 
the relationship between public-sector healthcare expenditure, and prostate cancer mortality (A), breast 602 
cancer mortality (B), male colorectal cancer mortality (C), female colorectal cancer mortality (D), male 603 
lung cancer mortality (E), female lung cancer mortality (F), treatable cancer mortality (G), untreatable 604 
cancer mortality (H), and all-cancer mortality (I). Analyses were conducted with controls for population 605 
size, population structure (proportion of population below 14 years of age and above 65 years of age), 606 
and country-specific differences in healthcare infrastructure. Data are also shown for 1-, 2-, 3-, 4-, and 607 
5-year time-lag analyses. Economic data were obtained from the World Bank.
25
 Cancer mortality data 608 
(deaths per 100 000) were obtained from the World Health Organisation Mortality Database 2013.
23
 * 609 
p<0.05; ** p<0.01; *** p<0.001. 610 
 611 
Figure 5. Possible causal pathways for the observed associations 612 
PEH, Public-sector expenditure on healthcare; SES, Socioeconomic status.  613 
614 
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TABLES 615 
Country/Grouping Population 2009 Country/Grouping 
Population 
2009 
Albania 3 151 185 Luxembourg 497 783 
Argentina 40 023 641 Macedonia 2 100 558 
Armenia 2 968 154 Malta 413 991 
Australia 21 778 800 Mauritius 1 275 032 
Austria 8 365 275 Mexico 116 815 612  
Azerbaijan 8 947 243 Moldova 3 565 603 
Barbados 279 006 Netherlands 16 530 388 
Belgium 10 796 493 New Zealand 4 315 800 
Belize 301 016 Nicaragua 5 743 329 
Brazil 193 490 922 Norway 4 828 726 
Bulgaria 7 585 131 Panama 3 615 846 
Canada 33 726 915 Paraguay 6 347 383 
Chile 16 991 729 Peru 28 934 303 
Colombia 45 802 561 Philippines 91 886 400 
Costa Rica 4 601 424 Poland 38 151 603 
Croatia 4 429 000 Portugal 10 632 482 
Cuba 11 288 826 Romania 21 480 401 
Czech Republic 10 487 178 Russian Federation 141 910 000 
Denmark 5 523 095 Serbia 7 320 807 
Dominican Republic 9 884 265 Singapore 4 987 600 
Ecuador 14 756 424 Slovak Republic 5 418 590 
Egypt 76 775 023 Slovenia 2 039 669 
El Salvador 6 183 484 Spain 45 908 594 
Estonia 1 340 271 Suriname 520 173 
Finland 5 338 871 Sweden 9 298 515 
France 64 702 921 Switzerland 7 743 831 
Georgia 4 410 900 Tajikistan 7 447 396 
Germany 81 902 307 Thailand 66 277 335 
Greece 11 282 760 Trinidad and Tobago 1 322 518 
Guatemala 13 988 988 Turkmenistan 4 978 962 
Hungary 10 022 650 Ukraine 46 053 300 
Iceland 318 499 United Kingdom 61 811 027 
Republic of Ireland 4 458 942 United States 306 771 529 
Israel 7 485 600 Uruguay 3 360 431 
Italy 60 192 698 Uzbekistan 27 767 400 
Japan 127 557 958 Venezuela 28 583 040 
Kazakhstan 16 093 481 High-income 1 066 391 720 
Republic of Korea 49 182 000 Middle-income  188 342 304 
Kuwait 2 850 102 UHC 641 437 562 
Kyrgyz Republic 5 383 300 Non-UHC 613 296 462 
Latvia 2 254 834 Very high human development index 849 195 806 
Lithuania 3 339 456 High human development index 405 538 218 
Table 1: Population estimates of countries included in multiple regression and time-series 617 
analyses, 2009. Population estimates were obtained from the World Bank (data code: 618 
SP.POP.TOTL).
20 
For country groupings, populations are calculated only for those countries 619 
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included in the time-series analysis as per figure 1. UHC, Universal healthcare coverage.620 
25 
 
 621 
 622 
 Table 2: Controls used in multiple regression and sensitivity analyses. Data were obtained from 623 
the World Bank.
 20 
PEH, Public-sector expenditure on healthcare. 624 
625 
 Common controls 
Robustness check 
control 
Particular control 
Total number of 
controls 
Unemploym
ent dataset 
(75 
countries) 
Population size 
 
Proportion of 
population less than 
15 years of age 
 
Proportion of 
population over 65 
years of age 
 
Economic 
Inflation 
GDP per capita changes 
Base interest rates 
80 
Resource availability 
Number of physicians per 
100 000 population; 
Number of hospital beds per 
100 000 population 
79 
Infrastructure 
Urbanisation; 
Access to water; 
Calorie intake 
80 
Out-of-pocket spending Out-of-pocket expenditure 78 
WHO data quality 
check 
N/A 
(Re-run analysis using data 
classified as Level 1 or 
Level 2 in quality by the 
WHO) 
77 
Income 
(2 categories coded into 1 
dummy variable) 
78 
Human development 
index 
(3 categories coded into 2 
dummy variables) 
79 
PEH dataset 
(79 
countries) 
Population size 
 
Proportion of 
population less than 
15 years of age 
 
Proportion of 
population over 65 
years of age 
 
Economic 
Inflation; 
GDP per capita changes; 
Base interest rates 
84 
Resource availability 
Number of physicians per 
100 000 population; 
Number of hospital beds per 
100 000 population 
83 
Infrastructure 
Urbanisation; 
Access to water; 
Calorie intake 
84 
Out-of-pocket spending Out-of-pocket expenditure 82 
WHO data quality 
check 
N/A 
(Re-run analysis using data 
classified as Level 1 or 
Level 2 in quality by the 
WHO) 
81 
Income 
(2 categories coded into 1 
dummy variable) 
82 
Human development 
index 
(3 categories coded into 2 
dummy variables) 
83 
26 
 
 626 
Table 3: Unemployment and cancer mortality rates controlling for universal healthcare coverage. 627 
Countries were classified as universal healthcare coverage (UHC) countries according to whether they 628 
were assessed to have met all of the following previously described conditions: legislation mandating 629 
UHC; >90% healthcare coverage; and >90% skilled birth attendance. 630 
631 
Cancer mortality in 
year of 
unemployment rise 
(deaths per 100 000) 
Co-efficient 
Robust 
standard error 
p Value 
Lower 
confidence 
interval (95%) 
Upper 
confidence 
interval (95%) 
Prostate cancer 0.0975 (0.1025) 0.3422 –0.1042 0.2992 
Breast (female) 
cancer 
0.0802 (0.0763) 0.2939 –0.0699 0.2302 
Colorectal (male) 
cancer 
–0.0679 (0.0589) 0.2495 –0.1838 0.0479 
Colorectal (female) 
cancer 
–0.0306 (0.0384) 0.4263 –0.1062 0.0450 
Lung (male) cancer –0.0126 (0.1753) 0.9428 –0.3575 0.3324 
Lung (female) 
cancer 
–0.0143 (0.0454) 0.7534 –0.1035 0.0750 
Treatable cancers 0.0319 (0.0692) 0.6449 –0.1037 0.1675 
Untreatable cancers 0.0758 (0.061) 0.2142 -0.0437 0.1952 
All cancers 0.0525 (0.1778) 0.7679 –0.2970 0.4019 
27 
 
 632 
 633 
Table 4: PEH and cancer mortality rates controlling for universal healthcare coverage. 634 
Countries were classified as universal healthcare coverage (UHC) countries according to whether 635 
they were assessed to have met all of the following previously described conditions: legislation 636 
mandating UHC; >90% healthcare coverage; and >90% skilled birth attendance. PEH, Public-637 
sector expenditure on healthcare. * p<0.05; ** p<0.01; *** p<0.001 638 
 639 
Cancer mortality in 
year of PEH rise 
(deaths per 100 000) 
Co-efficient 
Robust 
standard error 
p Value 
Lower 
confidence 
interval (95%) 
Upper 
confidence 
interval (95%) 
Prostate cancer –0.0009 (0.0001) 1.052×10
-10
*** –0.0011 –0.0006 
Breast (female) 
cancer 
–0.0009 (0.0001) 1.013×10-10*** –0.0012 –0.0007 
Colorectal (male) 
cancer 
–3×10-5 (0.0003) 0.9126 –0.0006 0.0006 
Colorectal (female) 
cancer 
–0.0004 (0.0001) 1.04×10-5*** –0.0011 –0.0002 
Lung (male) cancer –0.0007 (0.0003) 0.0087** –0.0012 –0.0002 
Lung (female) 
cancer 
0.0005 (0.0001) 2.19×10
-5
*** 0.0003 0.0007 
Treatable cancers –0.0022 (0.0005) 8.074×10
-6
*** –0.0032 –0.0012 
Untreatable cancers 0.0008 (0.0004) 0.0341* 0.0001 0.0016 
All cancers –0.0016 (0.0005) 1.7×10
-6
*** –0.0026 –0.0006 
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Dear Mrs Hart, 
 
RE: THELANCET-D-15-05399R1, Economic downturns, universal healthcare 
coverage, and cancer mortality in high- and middle-income countries, 1990-2010. 
 
We would like to thank the editorial board and the referees for their contributions to 
and constructive comments on our manuscript. We have carefully considered the 
reviewers’ comments and revised our manuscript accordingly. In particular, we would 
like to highlight the change in title to the manuscript from “Economic downturns, 
universal health coverage, and cancer mortality: a global analysis, 1990-2010” to 
“Economic downturns, universal healthcare coverage, and cancer mortality in high- 
and middle-income countries, 1990–2010” as suggested by one of the reviewers. 
 
We have provided systematic responses to the reviewers’ comments. Please note that 
amendments to the manuscript that are in response to the reviewers' comments are 
highlighted as tracked changes. 
 
We hope we have clarified the points raised by the referees to your satisfaction and 
that you now consider the revised manuscript acceptable for publication. 
 
Yours sincerely 
 
Mahiben Maruthappu & Johnathan Watkins 
  
*Reply to Reviewers Comments
REVIEWER 4 
 
Most reviewers' suggestions have been addressed. 
 
Given the correlational nature of the study, I would use an additionally cautious 
wording in the interpretation, but this is left to the authors' choice. 
 
Our response > We have now amended the wording in the Interpretation in the 
Abstract to highlight the correlative nature of the study: 
 
“There is evidence that UHC protects against mortality increases associated 
with rises in unemployment…” 
 
In the Discussion section we also added an additional cautionary language: 
 
“…implying that UHC could have had a protective effect against the 
possible impact of unemployment.” 
 
 
REVIEWER 5 
 
General Comments 
Overall this is a very well written manuscript! 
The authors use data from SELECT high income and middle income countries to 
study the impact of macroeconomics variable (unemployment, public sector 
expenditure on health care, universal healthcare coverage and income, on cancer 
mortality. 
 
Major comments 
Comment #1: Title: The title of the paper is a little mis-leading. It says "global 
analysis." With the exclusion of countries such as China, India and countries from 
Sub-Sahara Africa; the title should say something like "Economic downturns, 
universal health coverage, and cancer mortality in select high and middle income 
countries, 1990-2010" 
 Our response > We agree with the reviewer’s point and have amended the title of 
the paper to “Economic downturns, universal healthcare coverage, and cancer 
mortality in high- and middle-income countries, 1990–2010”. 
 
Comment #2: There may be a different picture, if the analysis is stratified into high 
income, middle income and low-income countries. 
 
Our response > We acknowledge the absence of quality data for low-income 
countries. As such, we have confined our analyses examining the role of income 
to high- and middle-income economies. We conducted fixed-effect regressions 
using the income status of a country as a balancing variable. We refer the 
reviewer to Table S8 for the results of these. We also conducted time-series 
analyses for high- and middle-income groups of countries, the results for which 
we refer the reviewer to Table S10. 
 
Minor comments 
Comment #3: Abstract (Method). Did all the countries included in the study 
experience sharp unemployment rise in between 2008 and 2010? 
 
Our response > We have now amended the text to point out that the sharp 
unemployment rise was experienced in many but not all countries. 
 
“Trend analysis was used to project mortality rates based on trends prior to 
the sharp unemployment rise experienced by many countries from 2008 to 
2010…” 
 
Comment #4: Methods: Need to indicate what criteria was used to classify countries 
into high and middle income.  It is important to include the reason why India, China 
and countries from Sub-Saharan Africa (SSA) are not included in the analysis. 
Without India, China and countries from Low income countries (such as those in 
SSA), this can hardly be called a "global analysis." 
 
Our response > We have now highlighted the reason that data from China, India 
and SSA countries were not included in the Methods section as follows: 
 
“Notably, at the time data were collected, complete cancer mortality data 
were unavailable for China, India, and countries from sub-Saharan 
Africa.” 
 
Comment #5: Results (Trend analysis). Brief mention is made of stratifying countries 
by income. This deserves more attention. 
 
Our response > We have now added notes to the Methods and the Results that 
income stratification was done based on the World Bank’s Atlas method. 
 
In the Methods: 
 
“Classification of countries into high- and middle-income was done 
according to the World Bank’s Atlas Method.25 In brief, middle-income 
countries are those with a gross national income per capita of more than $1 
045 but less than $12 736, whereas high-income economies are those with a 
gross national income per capita of $12 736 or more.” 
 
In the Results: 
 
“31 high-income countries and 4 middle-income countries as classified by 
the World Bank using the Atlas Method;
25” 
 
and 
 
“Stratifying countries by income using the World Bank’s classification…” 
 
Comment #6: Discussion (Limitation). Suggest mentioning that less than half of the 
countries in the world are included in this study. Highlight reasons why. 
 
Our response > We agree with the reviewer that this is an important point for 
the reader to appreciate. We have previously addressed a similar comment on 
the Discussion as follows: 
 
“Linked to this, we acknowledge the reduced global reach of our study due 
to the lack of data for low-income countries as well as China and India. 
Indeed, an examination of whether our findings hold in lower income 
countries where it is possible that mortality rates for certain cancer types 
have been rising rather than falling would offer valuable insight.” 
 
Comment #7: Discussion. Figure S is mentioned, but I cannot find it. 
 
Our response > We believe the reviewer is referring to Figure S2 as mentioned in 
the following sentence: 
 
“These periods were chosen so as to correspond with the sharp upturn in 
unemployment observed from 2008 onwards (figure S2).” 
 
We have checked and can confirm that figure S2 was included in the revised 
submission, and will be included among the supplementary figures in this second 
revision. 
 
Figure 1
61 countries for which complete all-cancer 
mortality data 
were available from 2000 to 2010 
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420 groupings by: 
• 35 countries; 
• male and female; and 
• 6 age-specific groups 
and all ages (0-84). 
26 countries with UHC 
Argentina, Canada, Chile, Croatia, Czech 
Republic, Denmark, Estonia, Finland, 
France, Germany, Hungary, Israel, Japan, 
Kuwait, Luxembourg, Netherlands, New 
Zealand, Norway, Republic of Korea, 
Romania, Slovakia, Slovenia, Spain, 
Sweden, Switzerland, United Kingdom. 
9 countries without UHC 
Barbados, Latvia, Lithuania, Malta, 
Mexico, Poland, Russian Federation, 
United States of America, Uruguay. 
Groupings excluded: 
• all 85+ age groups; and 
• 14 country- and sex-specific 
age groups with fewer than 20 
deaths in any calendar year. 
31 high income countries 
Barbados, Canada, Chile, Croatia, Czech 
Republic, Denmark, Estonia, Finland, 
France, Germany, Israel, Japan, Kuwait, 
Latvia, Lithuania, Luxembourg, Malta, 
Netherlands, New Zealand, Norway, 
Poland, Republic of Korea, Russian 
Federation, Slovakia, Slovenia, Spain, 
Sweden, Switzerland, United Kingdom, 
United States of America, Uruguay. 
4 middle income countries 
Argentina, Hungary, Mexico, Romania. 
22 very high HDI countries 
Barbados, Canada, Czech Republic, 
Denmark, Finland, France, Germany, 
Israel, Japan, Kuwait, Luxembourg, 
Malta, Netherlands, New Zealand, 
Norway, Republic of Korea, Slovenia, 
Spain, Sweden, Switzerland, United 
Kingdom, United States of America. 
13 high HDI countries 
Argentina, Chile, Croatia, Estonia, 
Hungary, Latvia, Lithuania, Mexico, 
Poland, Romania, Russian Federation, 
Slovakia, Uruguay. 
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Observed
1990 to 1994 APC=7 58*
1994 to 2001 APC=-0 31
2001 to 2007 APC=-4 09*
2007 to 2010 APC=11 36*
* The annual percent change
(APC) is significantly different
from zero at α=0 05.
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